« FDA Approvals - ATS Medical Shares Rise on FDA Approval (AP via Yahoo! | Main | FDA Announces Initiative to Bolster Generic Drug Program The U.S. »

FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for


FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with ... (The San Francisco Examiner)
COLLEGEVILLE, Pa. ( Map ) - COLLEGEVILLE, Pa., Oct. 24 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's supplemental New Drug Application (sNDA) for its first-in-class antibiotic Tygacil(R) (tigecycline) for the treatment of patients with community-acquired ...

Read my lips (The Express-Times)
When it comes to lipstick, red is good -- but lead is bad. And lead, according to a recent report, is found in small amounts as an ingredient in the pigment that provides the color in some lipstick brands. That's why deep-red lipsticks in particular have been singled out for testing.
 

©2006 FDA-News.com. All rights reserved.